A new Lyme disease vaccine made by Pfizer could lower infection rates.
A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal ...
Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent ...
Connecticut deer ticks are testing positive for Lyme disease at rates above 40% early in the season, a higher-than-usual rate ...
As the weather warms up, health experts are warning tick season is off to an early and potentially more dangerous start. With ...
A new vaccine from companies Pfizer and Valneva meant to prevent Lyme disease may be one step closer to approval.
Bay Area Lyme Foundation, a national nonprofit and leading sponsor of tick-borne disease research in the US, today announced publication of a new peer-reviewed article in Frontiers in Medicine ...
A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.
Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...
Scientists are working on developing a tick-repelling drug that could reduce infections.
A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the ...
A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the ...